Celldex Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
/ 
Frequently asked questions
To buy Celldex Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Celldex Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Celldex Therapeutics Inc. is CLDX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Celldex Therapeutics Inc. has its primary listing on NASDAQ. You can trade Celldex Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Celldex Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Celldex Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Celldex Therapeutics Inc..